NVIDIA
NVDA
Salesforce
CRM
Oracle
ORCL
Apple
AAPL
Meta Platforms
META
US Stock MarketDetailed Quotes
ORTX Orchard Therapeutics
- 0.0000
- 0.00000.00%
Trading Jan 28 09:30 ET
0Market Cap0.00P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open0.0000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)22.76MShares16.720052wk High0.00P/B0Float Cap16.585052wk Low--Dividend TTM11.73MShs Float216.4000Historical High--Div YieldTTM0.00%Amplitude3.6010Historical Low--Avg Price1Lot Size
Orchard Therapeutics News
Analysts Offer Insights on Healthcare Companies: Apellis Pharmaceuticals (APLS), Neurocrine (NBIX) and Orchard Therapeutics (ORTX)
Stifel Downgrades Orchard Therapeutics to Hold, Announces $16 Price Target
Orchard Therapeutics Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Orchard Therapeutics, Maintains $15 Price Target
Oppenheimer Adjusts Orchard Therapeutics Price Target to $34 From $37, Maintains Outperform Rating
Oppenheimer Maintains Outperform on Orchard Therapeutics, Lowers Price Target to $34
Cantor Fitzgerald Maintains Overweight on Orchard Therapeutics, Raises Price Target to $15
Oppenheimer Adjusts Orchard Therapeutics Price Target to $37 From $5, Maintains Outperform Rating
No More
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.